S100A7 and oral lichen planus: The differential expression of AMPs in oral lichen planus patients, characterized by reduced levels of S100A8 and S100A9 and increased levels of S100A7, suggests alterations in the chemical barrier that may enhance susceptibility to oral infections and inflammation.